BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9154342)

  • 1. A site-directed mutagenesis study on the conserved alanine residue in the distal third intracellular loops of cholecystokininB and neurotensin receptors.
    Wang HL
    Br J Pharmacol; 1997 May; 121(2):310-6. PubMed ID: 9154342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors.
    Wang HL
    J Neurochem; 1997 Apr; 68(4):1728-35. PubMed ID: 9084447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis.
    Jagerschmidt A; Guillaume N; Roques BP; Noble F
    Mol Pharmacol; 1998 May; 53(5):878-85. PubMed ID: 9584214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction.
    Jagerschmidt A; Guillaume N; Goudreau N; Maigret B; Roques BP
    Mol Pharmacol; 1995 Nov; 48(5):783-9. PubMed ID: 7476907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of constitutive activation or inactivation of the platelet-activating factor receptor by glutamate substitution of alanine 230.
    Carlson SA; Chatterjee TK; Fisher RA
    Recept Signal Transduct; 1996; 6(2):111-20. PubMed ID: 9015866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
    Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
    Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
    Yamada M; Yamada M; Watson MA; Richelson E
    Mol Pharmacol; 1994 Sep; 46(3):470-6. PubMed ID: 7935327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of two different cholecystokinin receptors in Xenopus oocytes injected with mRNA from rabbit pancreas and rat hippocampus.
    Shigeri Y; Shinohara S; Murata S; Fujimoto M; Kawasaki K
    Jpn J Pharmacol; 1996 Sep; 72(1):9-15. PubMed ID: 8902594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
    Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different signaling pathway between sphingosine-1-phosphate and lysophosphatidic acid in Xenopus oocytes: functional coupling of the sphingosine-1-phosphate receptor to PLC-xbeta in Xenopus oocytes.
    Noh SJ; Kim MJ; Shim S; Han JK
    J Cell Physiol; 1998 Aug; 176(2):412-23. PubMed ID: 9648929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the ERC motif in the proximal part of the second intracellular loop and the C-terminal domain of the human prostaglandin F2alpha receptor (hFP-R) in G-protein coupling control.
    Pathe-Neuschäfer-Rube A; Neuschäfer-Rube F; Püschel GP
    Biochem J; 2005 May; 388(Pt 1):317-24. PubMed ID: 15651980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of free radicals and amyloid beta protein on the currents of expressed rat receptors in Xenopus oocytes.
    Huang F; Li W; Zhang B; Cui X; Han Z; Fang Z; Cai S; Yin L; Wang L
    Chin Med J (Engl); 2001 Mar; 114(3):244-7. PubMed ID: 11780306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
    Xie J; Dernovici S; Ribeiro P
    J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single amino acid change within the ion-channel domain of the gamma-aminobutyric acid rho1 receptor accelerates desensitization and increases taurine agonism.
    Martínez-Torres A; Miledi R
    Arch Med Res; 2004; 35(3):194-8. PubMed ID: 15163459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCKA receptor activation stimulates p130(Cas) tyrosine phosphorylation, translocation, and association with Crk in rat pancreatic acinar cells.
    Ferris HA; Tapia JA; García LJ; Jensen RT
    Biochemistry; 1999 Feb; 38(5):1497-508. PubMed ID: 9931015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential involvement of intracellular domains of the rat NTS1 neurotensin receptor in coupling to G proteins: a molecular basis for agonist-directed trafficking of receptor stimulus.
    Skrzydelski D; Lhiaubet AM; Lebeau A; Forgez P; Yamada M; Hermans E; Rostene W; Pelaprat D
    Mol Pharmacol; 2003 Aug; 64(2):421-9. PubMed ID: 12869647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved polar residues in the transmembrane domain of the human tachykinin NK2 receptor: functional roles and structural implications.
    Donnelly D; Maudsley S; Gent JP; Moser RN; Hurrell CR; Findlay JB
    Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):55-61. PubMed ID: 10085227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
    Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
    Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
    Heydorn A; Ward RJ; Jorgensen R; Rosenkilde MM; Frimurer TM; Milligan G; Kostenis E
    Mol Pharmacol; 2004 Aug; 66(2):250-9. PubMed ID: 15266015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural determinants of agonist-induced signaling and regulation of the angiotensin AT1 receptor.
    Hunyady L; Gáborik Z; Shah BH; Jagadeesh G; Clark AJ; Catt KJ
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):89-100. PubMed ID: 15134806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.